Methylprednisolone to Prednisone Conversion
The standard conversion ratio is 4 mg methylprednisolone = 5 mg prednisone (or 1:1.25), meaning methylprednisolone is approximately 1.25 times more potent than prednisone. 1
Conversion Formula
To convert methylprednisolone to prednisone:
- Prednisone dose = Methylprednisolone dose × 1.25
To convert prednisone to methylprednisolone:
- Methylprednisolone dose = Prednisone dose × 0.8
Practical Examples
- Methylprednisolone 48 mg/day = Prednisone 60 mg/day 1
- Methylprednisolone 32 mg/day = Prednisone 40 mg/day
- Methylprednisolone 16 mg/day = Prednisone 20 mg/day
- Methylprednisolone 4 mg/day = Prednisone 5 mg/day
Clinical Context from Guidelines
Multiple high-quality guidelines consistently reference this conversion ratio across different disease states:
For immune-related adverse events, guidelines specify "prednisone 0.5-1 mg/kg/day (or equivalent dose of methylprednisolone)" 2, implicitly using the 1:1.25 ratio when calculating equivalent doses.
For sudden hearing loss, the AAO-HNS guideline explicitly states: "Prednisone is 4 times, methylprednisolone is 5 times, and dexamethasone is 25 times more powerful than hydrocortisone. The equivalent dose of prednisone 60 mg is 48 mg for methylprednisolone and 10 mg for dexamethasone." 1
For lupus nephritis, treatment protocols use methylprednisolone pulses followed by oral prednisone, with dosing schemes that reflect this conversion (e.g., methylprednisolone 0.5-0.75 g IV pulses transitioning to prednisone 0.5 mg/kg/day) 3, 4, 5.
Important Caveats
Route of Administration Matters
The conversion ratio applies primarily to oral-to-oral or IV-to-IV comparisons. When switching from IV methylprednisolone to oral prednisone, bioavailability differences become relevant. Research shows that 1250 mg oral prednisone produces similar bioavailability (AUC) to 1000 mg IV methylprednisolone 6, suggesting approximately equivalent absorption when given orally at these high doses.
Dose-Dependent Pharmacokinetics
Prednisone exhibits nonlinear, dose-dependent pharmacokinetics due to saturable protein binding, while methylprednisolone shows linear pharmacokinetics 7. At higher doses, prednisone's clearance increases and its protein binding saturates, making precise dose equivalency more complex. This is why methylprednisolone may be preferred for high-dose pulse therapy where predictable pharmacokinetics are important 7.
Duration and Indication
The 1:1.25 conversion ratio is most reliable for:
- Short-term therapy (days to weeks)
- Moderate to high doses (where both drugs are above their protein-binding saturation thresholds)
- Maintenance therapy at lower doses
For very high-dose pulse therapy (e.g., 500-1000 mg methylprednisolone IV), direct mg-for-mg conversion may not be appropriate—these regimens are typically followed by standard-dose oral prednisone rather than attempting to maintain equivalent ultra-high doses orally 3, 4.
FDA Labeling Confirmation
The FDA label for methylprednisolone explicitly states: "4 mg of methylprednisolone is equivalent to 5 mg of prednisolone" 8, confirming the 1:1.25 ratio. Note that prednisolone and prednisone are considered therapeutically equivalent in most contexts (prednisone is converted to prednisolone in the liver).
Practical Application Algorithm
- For routine dose conversion: Multiply methylprednisolone dose by 1.25 to get prednisone equivalent
- For high-dose pulse therapy: Use institutional protocols rather than direct conversion—typically IV methylprednisolone pulses are followed by standard oral prednisone tapers (not ultra-high oral doses)
- When switching from IV to oral: Consider using the same mg-for-mg dose initially if using very high doses (≥1000 mg), as oral bioavailability at these doses approaches IV 6
- For maintenance therapy: Use the 1:1.25 ratio consistently